Table 4. Study proportion contribution matrix P* for the network of topical antibiotics without steroids for chronically discharging ears.
Cells show the proportion contribution of individual studies indicated in the column to the network meta-analysis treatment effects indicated in the rows.
Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | Study 6 | Study 7 | Study 8 | Study 9 | Study
10 |
Study
11 |
Study
12 |
Study
13 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
xy | 19.7 | 63.4 | 2.8 | 0.5 | 0.6 | 0.4 | 0.6 | 0.7 | 2.7 | 1.3 | 0.8 | 2.3 | 4.2 |
xu | 9.3 | 40.4 | 8.8 | 4.4 | 5.3 | 3.5 | 5.1 | 5.4 | 6.9 | 6.5 | 3.9 | 0.2 | 0.3 |
xv | 7.6 | 67.1 | 4.2 | 0.8 | 1 | 0.6 | 0.9 | 1 | 4.1 | 2 | 1.2 | 3.4 | 6.2 |
yu | 0.3 | 4.63 | 13.6 | 10.5 | 12.7 | 8.4 | 12.2 | 12.9 | 12.2 | 4.3 | 2.6 | 2 | 3.7 |
yv | 1.4 | 23.5 | 12.1 | 2 | 2.4 | 1.6 | 2.3 | 2.4 | 12.2 | 5 | 3 | 11.3 | 20.7 |
uv | 0.6 | 8.4 | 19 | 3.1 | 3.8 | 2.5 | 3.6 | 3.8 | 14.4 | 19.1 | 11.5 | 3.6 | 6.7 |
x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic.